APOE4 and family: should your relatives get tested?

The moment you learn your APOE genotype, you have also learned something about the people you share DNA with. Your parents, your siblings, and your kids are all implicated by your result, in probabilities you can actually work out. That raises a question that is as much about family dynamics as biology: do they need to know, and is it your place to tell them? Here is how to think it through, starting with what your result actually says about them.

What your result says about your family

You inherited one APOE allele from each parent, so your genotype reflects on both of them and shifts the odds for everyone else. Here is the rough math for the three relationships people ask about.

Relationship	What your ε4 implies for them
Each child	Inherits one of your two alleles; one ε4 in you means a 50% chance they get it
Parents	At least one carried an ε4 (it is where your copy came from)
Full sibling	Roughly 1 in 2 chance of carrying an ε4, versus about 1 in 4 in the general population

The detail underneath each row:

Children. Each child inherits exactly one of your two alleles.

• If you are ε3/ε4, each child has a 50% chance of inheriting your ε4. If the other parent also carries an ε4, each child then has a 25% chance of being ε4/ε4.
• If you are ε4/ε4, every child inherits at least one ε4 from you, so each is at minimum ε3/ε4. If the other parent also carries an ε4, each child has a 50% chance of being ε4/ε4.

Parents. If you carry an ε4, at least one of your parents did too. If you are ε4/ε4, both parents carried at least one ε4.

Siblings. This is the case people ask about most, and the honest answer is “it depends on your parents’ genotypes.” As a rough rule, if you carry an ε4, a full sibling has a meaningfully higher than baseline chance of carrying one too, often around 1 in 2, versus roughly 1 in 4 in the general population. It is a probability, not a readout: a sibling’s status cannot be read straight off yours.

APOE is not the “family Alzheimer’s gene”

This distinction matters, because it changes the stakes entirely, and it is easy to conflate the two.

APOE4 is a risk factor, the common kind that nudges the odds. Separately, a small number of families carry rare, dominantly-inherited mutations (in genes called APP, PSEN1, and PSEN2) that cause early-onset Alzheimer’s, often in the 30s to 50s, with very high penetrance (near-certain for PSEN1, somewhat lower for some APP and PSEN2 variants). To keep this in proportion: that autosomal-dominant, early-onset form accounts for fewer than about 1 to 5% of all Alzheimer’s cases. It is rare, it is a different biological story from APOE4, and the stakes are much higher, including a near-predictable age of onset with implications for reproductive planning. If your family has multiple early-onset cases, that is a flag to involve a genetic counselor, not just to check APOE.

Should they test?

There is no universal answer. The same trade-offs that apply to your own testing decision apply to relatives, magnified by the fact that it is their choice to make:

• It is a risk factor, not a diagnosis. A relative learns odds, not fate.
• There is no APOE-specific treatment to act on. The response is the same set of modifiable levers recommended for brain and heart health generally, worth doing regardless of genotype.
• People differ in whether they want to know. Some find a result motivating; others find it a source of anxiety they would rather not carry.
• Insurance considerations (life, disability, long-term-care) apply to them too.

A reasonable stance: relatives can capture most of the practical benefit, getting serious about blood pressure, fitness, sleep, and metabolic health, without testing at all. Testing mainly adds value when the result would genuinely change a decision.

How to share it well

If you do bring it up, how you frame it matters more than the result itself.

• Lead with autonomy. Offer the information; do not impose a test. “I learned I’m a carrier, and you might want to know your options” respects their choice.
• Mind the unsolicited. A sibling or parent may not want this knowledge, especially older relatives for whom it changes little.
• Be careful with kids. Professional guidelines (including the American College of Medical Genetics) generally advise against testing minors for adult-onset conditions like this. The reasoning: the child’s right to decide for themselves as an adult, plus the fact that nothing about the result is actionable in childhood.
• Frame it around the levers, not the fear. The most useful thing you can pass along is not the gene result but the message that habits matter, for everyone.

When to bring in a professional

If your family has a strong history of Alzheimer’s, particularly early-onset cases, that is a flag to involve a genetic counselor, who can put APOE in context, discuss the rarer high-impact genes, and help relatives decide on their own terms. The NSGC directory lists counselors.

Common questions

If I’m ε4/ε4, will my kids definitely get Alzheimer’s? No. They will each inherit one ε4 from you, making them at least ε3/ε4 carriers, but carrier status is a risk factor, not a diagnosis, and their other parent’s alleles and their own lifestyle matter a great deal.

Should I test my children? Generally not for an adult-onset risk factor. It is theirs to choose as adults, and it changes nothing actionable now.

The kindest version of this conversation is not a push to test. It is sharing what you have learned, pointing to the levers that help either way, and letting each person decide how much they want to know. This is general education, not medical advice.